CQDM to fund an international collaboration between Traffick Therapeutics, McGill University and the Lead Discovery Center
Montreal (Quebec), February 25, 2021—CQDM is proud to announce the launch of a $2,025,077 international collaborative project to support the preclinical stages of new drug candidates to treat an orphan lung disease. Led by Professor David Y. Thomas of McGill University, this multi-partner project focuses on the development of drugs addressing alpha-1 antitrypsin deficiency (A1AT), a